Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today […]
Altair Medical Secures $3.1m in Pre-Series A financing
UK based Altair Medical today announced it has secured £2.25m ($3.1m) of Pre-Series A funding […]
Calixar Invests €1 Million in Pipeline of Highly Druggable Membrane Protein Targets and Native Antigens
Calixar, a biotechnology company with ten years expertise in the isolation of fully native membrane […]
Zedsen Closes $12M Series B, Expands Team with Appointment of New CTO
Zedsen, a UK health tech company with a revolutionary non-invasive technology that helps consumers understand […]
Brii Biosciences (Brii Bio) Closes US$155 Million Series C Financing
Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet […]
Omega Therapeutics to Advance Pipeline and Platform Development with Additional Financing
Omega Therapeutics, Inc. (“Omega“), a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to […]
Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform
Ro, the healthcare technology company, today announced it has completed a $500 million Series D […]
Chime Biologics Completes US$190M Series A+ Financing
Chime Biologics Limited, a China-based, world-class CDMO company, announced today that it has secured a total […]
Better Health Announces $3.5 Million Seed Funding To Build The Next-Generation Medical Supplier, Reinventing a $60B Market
Better Health, the next-generation medical supplier offering a seamless e-commerce experience and white-glove service to […]
Q'Apel Medical raises $22 Million to grow innovative Neurovascular access platform & Scott Huennekens joins Board of Directors
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more